ADAGIO MEDICAL HOLDINGS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$25.24 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-27
- ADAGIO MEDICAL HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$25.24M.
- ADAGIO MEDICAL HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$36.52M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 5 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|
| 2025-12-31 | -$25.24M 10-K · filed 2026-03-27 | |
| 2024-12-31 | -$76.89M 10-K · filed 2026-03-27 | |
| 2023-12-31 | -$36.52M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |